MK-6213

N/A

Report date: 2023/11/10 15:44:31
NME

Base Information

Drug NameMK-6213
Drug Alias NameMK-6213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNiemann-Pick C1-like protein 1 inhibitorsCholesterol absorption inhibitors
TargetsNiemann-Pick C1-like protein 1
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A